240 related articles for article (PubMed ID: 30218283)
1. Pharmacological Modulation of Vagal Nerve Activity in Cardiovascular Diseases.
Liu L; Zhao M; Yu X; Zang W
Neurosci Bull; 2019 Feb; 35(1):156-166. PubMed ID: 30218283
[TBL] [Abstract][Full Text] [Related]
2. Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases.
He X; Zhao M; Bi X; Sun L; Yu X; Zhao M; Zang W
Br J Pharmacol; 2015 Dec; 172(23):5489-500. PubMed ID: 25378088
[TBL] [Abstract][Full Text] [Related]
3. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
[TBL] [Abstract][Full Text] [Related]
4. Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function.
Schultheis AH; Bassett DJ; Fryer AD
J Appl Physiol (1985); 1994 Mar; 76(3):1088-97. PubMed ID: 8005850
[TBL] [Abstract][Full Text] [Related]
5. Vagal nerve modulation: a promising new therapeutic approach for cardiovascular diseases.
Zhao M; Sun L; Liu JJ; Wang H; Miao Y; Zang WJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):701-5. PubMed ID: 22077771
[TBL] [Abstract][Full Text] [Related]
6. [Vagal control of cardiac functions and vagal protection of ischemic myocardium].
Zang WJ; Sun L; Yu XJ; Lv J; Chen LN; Liu BH
Sheng Li Xue Bao; 2008 Aug; 60(4):443-52. PubMed ID: 18690385
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.
Intachai K; C Chattipakorn S; Chattipakorn N; Shinlapawittayatorn K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134547
[TBL] [Abstract][Full Text] [Related]
8. Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation.
Brack KE; Coote JH; Ng GA
Cardiovasc Res; 2011 Aug; 91(3):437-46. PubMed ID: 21576131
[TBL] [Abstract][Full Text] [Related]
9. Acute adenosine increases cardiac vagal and reduces sympathetic efferent nerve activities in rats.
da Silva VJ; Gnecchi-Ruscone T; Bellina V; Oliveira M; Maciel L; de Carvalho AC; Salgado HC; Bergamaschi CM; Tobaldini E; Porta A; Montano N
Exp Physiol; 2012 Jun; 97(6):719-29. PubMed ID: 22366563
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic and parasympathetic innervation in cancer: therapeutic implications.
Kamiya A; Hiyama T; Fujimura A; Yoshikawa S
Clin Auton Res; 2021 Apr; 31(2):165-178. PubMed ID: 32926324
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to restore parasympathetic activity to the heart in cardiorespiratory diseases.
Dyavanapalli J
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1153-H1161. PubMed ID: 33035444
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic drugs and the modulation of autonomic control of heart rate in rabbits.
Murthy VS; Hwang TF
Fed Proc; 1986 Jul; 45(8):2186-90. PubMed ID: 3013694
[TBL] [Abstract][Full Text] [Related]
13. Changes in vagal reactivity to the sympathicotonia during the progression of heart failure: from self-suppression to counteraction.
Milicevic G; Udiljak N; Milicevic T
Med Hypotheses; 2013 Aug; 81(2):264-7. PubMed ID: 23679996
[TBL] [Abstract][Full Text] [Related]
14. Targeting Cholinergic System to Modulate Liver Injury.
Jadeja RN; Rachakonda VP; Khurana S
Curr Drug Targets; 2018; 19(8):938-944. PubMed ID: 28625139
[TBL] [Abstract][Full Text] [Related]
15. [Muscarinic modulation of cardiac activity].
Sauviat MP
J Soc Biol; 1999; 193(6):469-80. PubMed ID: 10783705
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic modulation of the immune system presents new approaches for treating inflammation.
Hoover DB
Pharmacol Ther; 2017 Nov; 179():1-16. PubMed ID: 28529069
[TBL] [Abstract][Full Text] [Related]
17. The autonomic nervous system and hypertension.
Mancia G; Grassi G
Circ Res; 2014 May; 114(11):1804-14. PubMed ID: 24855203
[TBL] [Abstract][Full Text] [Related]
18. How to study sympatho-vagal balance in arterial hypertension and the effect of antihypertensive drugs?
Presciuttini B; Duprez D; De Buyzere M; Clement DL
Acta Cardiol; 1998; 53(3):143-52. PubMed ID: 9793567
[TBL] [Abstract][Full Text] [Related]
19. Progress in the study of vagal control of cardiac ventricles.
Zang WJ; Chen LN; Yu XJ
Sheng Li Xue Bao; 2005 Dec; 57(6):659-72. PubMed ID: 16344889
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
